Do parents of children with congenital malformations have a higher cancer risk? A nationwide study in Denmark

To investigate whether parents of children with congenital malformations more often developed cancer after birth of the child, a population-based case-control study in Denmark was undertaken. By linking the Cancer Registry with the Central Population Registry, we identified 8783 cancer patients having their first child born between 1977 and 1995 before the cancer was diagnosed. Parents of 41 206 firstborn children of a 10% random sample of newborns from the Birth Registry between 1980 and 1995 were identified as controls. We obtained malformation diagnoses of children of cases and controls by linking to the Hospital Discharge Registry. We estimated the association between malformation and cancer by using logistic regression, adjusting for maternal age at birth and sex of child. We found no increased risk of cancer in parents having children with malformations in general, but a higher cancer risk in parents of children born with cleft lip/palate, odds ratio (OR) for all cancer=1.8 (95% confidence interval 1.0–3.2), OR for lymphomas=4.2 (1.3–13.5) and OR for leukaemia=8.1 (2.0–33.7). This association was not restricted to cancer cases diagnosed shortly after birth of the child. Our results suggest a common genetic association between these diseases, but further studies are needed.

[1]  T. Shin,et al.  Transcriptional regulation of the human transforming growth factor-α gene , 1991 .

[2]  H. Adami,et al.  Maternal and perinatal risk factors for childhood leukemia. , 1991, Cancer research.

[3]  I. Vorobtsova Increased cancer risk as a genetic effect of ionizing radiation. , 1989, IARC scientific publications.

[4]  Vorobtsova Ie Increased cancer risk as a genetic effect of ionizing radiation. , 1989 .

[5]  J. Olsen,et al.  Selection bias in genetic-epidemiological studies of cleft lip and palate. , 1992, American journal of human genetics.

[6]  G. Brodeur,et al.  Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. , 1987, Cancer genetics and cytogenetics.

[7]  M. Privalsky,et al.  DNA recognition by the aberrant retinoic acid receptors implicated in human acute promyelocytic leukemia. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[8]  H. Hasle,et al.  Risks of leukaemia and solid tumours in individuals with Down's syndrome , 2000, The Lancet.

[9]  P. Infante,et al.  Carcinogenic, mutagenic and teratogenic risks associated with vinyl chloride. , 1976, Mutation research.

[10]  J. Lary,et al.  Sex differences in the prevalence of human birth defects: a population-based study. , 2001, Teratology.

[11]  C. Amos,et al.  Nonsyndromic cleft lip and palate is not associated with cancer or other birth defects. , 2000, American journal of medical genetics.

[12]  K. Christensen,et al.  Registration of congenital malformations in Denmark. , 1998, Danish medical bulletin.

[13]  A. Karjalainen,et al.  Case-control study of congenital anomalies in children of cancer patients. , 1993, BMJ.

[14]  J. Olsen,et al.  Pregnancy experience in women who later developed oestrogen- related cancers (Denmark) , 1998, Cancer Causes & Control.

[15]  L. Strong,et al.  Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. , 1998, American journal of human genetics.

[16]  T. Shin,et al.  Transcriptional regulation of the human transforming growth factor-alpha gene. , 1991, Molecular endocrinology.

[17]  M. Kelly,et al.  Maternal Age and Malformations in Singleton Births , 2000, Obstetrics and gynecology.

[18]  J. Mulvihill,et al.  Pregnancy outcome in cancer patients. Experience in a large cooperative group , 1987, Cancer.

[19]  J. Chessells,et al.  Deletions of chromosome 21 restricted to the leukemic cells of children with Down syndrome and leukemia , 1997, Leukemia.

[20]  P. Hartge,et al.  Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy , 2001, British Journal of Cancer.

[21]  L. Robison,et al.  Birth defects in offspring of adult survivors of childhood acute lymphoblastic leukemia: A Childrens Cancer Group/National Institutes of Health report , 1996, Cancer.

[22]  T. F. Andersen,et al.  The Danish National Hospital Register. A valuable source of data for modern health sciences. , 1999, Danish medical bulletin.

[23]  H. Vainio,et al.  Carcinogenesis and teratogenesis may have common mechanisms. , 1989, Scandinavian journal of work, environment & health.

[24]  K. Christensen The 20th century Danish facial cleft population--epidemiological and genetic-epidemiological studies. , 1999, The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association.

[25]  WM Kast,et al.  Effects of TGF-β on the immune system: implications for cancer immunotherapy , 1999, Leukemia.

[26]  J. McLachlan,et al.  From malformations to molecular mechanisms in the male: three decades of research on endocrine disrupters , 2001, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[27]  K. Christensen,et al.  Cleft lip (+/- cleft palate) in Danish twins, 1970-1990. , 1993, American journal of medical genetics.

[28]  M. Khoury,et al.  Risk of childhood cancer for infants with birth defects. I. A record-linkage study, Atlanta, Georgia, 1968-1988. , 1993, American journal of epidemiology.

[29]  G. Shaw,et al.  Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally , 1995, The Lancet.

[30]  C. Houdayer,et al.  Orofacial cleft defects: inference from nature and nurture. , 1998, Annales de genetique.

[31]  D. Duffy,et al.  Cleft lip with or without cleft palate: associations with transforming growth factor alpha and retinoic acid receptor loci. , 1992, American Journal of Human Genetics.

[32]  H. Storm,et al.  The Danish Cancer Registry--history, content, quality and use. , 1997, Danish medical bulletin.

[33]  K. D. de Visser,et al.  Effects of TGF-beta on the immune system: implications for cancer immunotherapy. , 1999, Leukemia.